Prepared and filed by St Ives Burrups

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

January 28, 2004
Date of Report (Date of earliest event reported)

APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

Delaware 1-4389 06-1534213
(State or Other Jurisdiction
of Incorporation)
(Commission
File No.)
(IRS Employer
Identification No.)

301 Merritt 7
Norwalk, Connecticut 06851

(Address of Principal Executive Offices, Including Zip Code)

(203) 840-2000
(Registrant’s telephone number, including area code)

 


Item 7. Financial Statements and Exhibits.

(c) Exhibits.

The following exhibits are filed with this Report:

  Exhibit No.   Description
       
  99.1   Press Release issued January 28, 2004, with respect to financial results for Applera and Applera’s Applied Biosystems Group.          
       
  99.2   Press Release issued January 28, 2004, with respect to financial results for Applera and Applera’s Celera Genomics Group.

Item 12. Results of Operations and Financial Condition.

On January 28, 2004, Applera Corporation (“Applera”) announced financial results for Applera and its business units for the second quarter of its 2004 fiscal year. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of a press release issued on January 28, 2004, with respect to financial results for the second quarter of fiscal year 2004 of Applera and Applera’s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on January 28, 2004, with respect to financial results for the second quarter of fiscal year 2004 of Applera and Applera’s Celera Genomics Group.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  APPLERA CORPORATION
     
     
  By:        /s/ Dennis L. Winger             
    Dennis L. Winger
    Senior Vice President and
    Chief Financial Officer

 

 

Dated: January 28, 2004

 


EXHIBIT INDEX

Exhibit No.   Description
     
99.1   Press Release issued January 28, 2004, with respect to financial results for Applera and Applera’s Applied Biosystems Group.
     
99.2   Press Release issued January 28, 2004, with respect to financial results for Applera and Applera’s Celera Genomics Group.